World AIDS day marked by new vaccine progress

GeoVax Labs chose World AIDS day to announce that it is launching a Phase II trial of a new vaccine at 12 sites in collaboration with the NIH and the HIV Vaccine Trials Network. The trial will study the effects of the vaccine on 225 volunteers. GeoVax was spun out of Emory University in 2001. FierceVaccines

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.